ontx stock latest news

Onconova Therapeutics ONTX -43 after the company reported wider-than-expected gaap loss per share for FY 2021 after markets closed on Thursday. Get the latest news and real-time alerts from Onconova Therapeutics Inc.

Onconova Therapeutics Inc Ontx Stock Message Board Investorshub

Onconova Therapeutics Inc ONTX shares closed today at 09 above its 52 week low of 228 giving the company a market cap of 49M.

. NASDAQ Updated Mar 30 2022 1029 PM ONTX 188 006 309. ONTX shares have risen 432 or 008 per share as on 120952 est today. 76637 shares of the companys stock were exchanged compared to its average volume of 194857.

Onconova Therapeutics Inc NASDAQ. The stock has a two hundred day moving average of 522 and traded as low as 289. GlobeNewswire 800 AM ET 09242021.

View real-time stock prices and stock quotes for a full financial overview. Ad 1000 Strong Buy Stocks that Double the SP. The 5 year net cashflow from operations growth rate now stands at 203.

The stock has a market capitalization. ONTX stock at Seeking Alpha. Shares of ONTX traded up 001 on Thursday reaching 185.

The Fly team scours all sources of company news from mainstream to cutting edgethen filters out the noise to deliver shortform stories consisting of only market moving content. Get the latest Onconova Therapeutics Inc. ONTX stock quote history news and other vital information to help you with your stock trading and investing.

It focuses on discovering and developing small molecule drug candidates to treat cancer. After Opening the Day at 190 54521 shares of. The table below shows ONTXs growth in key financial areas numbers in millions of US.

Is a clinical-stage biopharmaceutical company which engages in the identification and development of oncology therapeutics. View the latest news buysell ratings SEC filings and insider transactions for your stocks. ONTX Complete Onconova Therapeutics Inc.

Onconova Therapeutics shares last traded at 300 with a volume of 405714 shares changing hands. Get daily stock ideas top-performing Wall Street analysts. ONTXs share price passed below its two hundred day moving average during trading on Tuesday.

The stock is currently down 98 year-to-date down 758 over the past 12 months and down 996 over the past five years. Get daily stock ideas top-performing Wall Street analysts. A number of analysts.

Over the past 49 months ONTXs revenue has gone down 590000. Stock Ideas and Recommendations. Latest ONTX News From Around the Web.

Stock news by MarketWatch. Latest ONCONOVA THERAPEUTICS ONTX stock news Onconova Therapeutics Inc. ONTX stock news and headlines to help you in your trading and investing decisions.

Find the latest news headlines from Onconova Therapeutics Inc. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. ONTX a biopharmaceutical company focused on discovering and developing novel products to treat cancer today announced the pricing of an underwritten public offering of 5000000 shares of its common stock at a public offering price of 420 per share.

The company reported net loss of 96 cents per. 02 2022 GLOBE NEWSWIRE -- Onconova Therapeutics Inc. Is a clinical-stage biopharmaceutical company which engages in the iden.

Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Premkumar Reddy on December 22 1998 and is. Find the latest Onconova Therapeutics Inc.

Onconova Therapeutics Inc. Stock Ideas and Recommendations. Its 4 year price growth rate is now at -9957.

View the latest news buysell ratings SEC filings and insider transactions for your stocks. ONTX a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer today announced that the Company will be participating in the Guggenheim Oncology Conference taking place virtually February 9. This week the Dow Jones Industrial Average fell 03 and the SP 500 fell 19.

According to 9 analysts the average rating for ONTX stock is Buy The 12-month stock price forecast is 102 which is. Its year over year price growth rate is now at 7098. The company was founded by Ramesh Kumar and E.

Onconova Therapeutics Inc Shares Close In On 52 Week Low Market Mover Nasdaq